Second, Philips' research application TissueMark2 that helps in automatic identification of tumor region and subsequent quantification for macro dissection. Third, Philips' research application Xplore2 that enables image and study data management, and biomarker discovery with additional tools that help streamline research and biomarker discovery.
Open platform for building digital pathology ecosystem
Philips IntelliSite Pathology Solution3 will add new capabilities in its open research platform allowing support of additional image file formats to its image management system, including DICOM. This could potentially offer users the ability to leverage prior investments in scanners and extend their utility as they grow their digital pathology networks. We are committed to work with partners to develop state of the art computational pathology applications via our open platform.
Ad Statistics
Times Displayed: 50459
Times Visited: 1437 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
Educational session
Philips will host a seminar & luncheon "Digital pathology moving from pilot to practice" on March 6th 12:00 – 1:00 pm CT in the Bowie Room at the San Antonio Grand Hyatt Hotel. The event will include discussions featuring Philips Digital Pathology Solutions' Esther Abels, guest speakers Andrew H. Beck, MD, PhD from Beth Israel Deaconess Medical Center and Anil Parwani, MD, PHD, MBA, professor at The Ohio State University, and Director of Pathology Informatics and Digital Pathology Shared Resource at The James Cancer Hospital. The event is open to all USCAP attendees.
For more information on Philips' presence at the 2017 United States and Canadian Academy of Pathology Annual Meeting, visit www.philips.com/digitalpathology and follow @Philips_Path for #USCAP17 updates throughout the event.
1) Visiopharm is the legal manufacturer of the breast IHC applications (HER2, ER, PR, Ki67). The applications are CE-IVD for Europe and Research Use Only for United States and Rest of the world.2) TissueMark and Xplore is a research application. PathXL is legal manufacturer. 3) Philips IntelliSite Pathology Solution is CE-IVD marked. In the United States, the Philips IntelliSite Pathology Solution pending review of a request for de novo classification.
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2016 sales of EUR 17.4 billion and employs approximately 71,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
SOURCE Royal Philips
Back to HCB News
